ANIP
Ani Pharmaceuticals IncCompany with tickers: ANIP
CIK
1023024
CUSIP
00182C103
Shares Outstanding
22,734,618
13F Activity (30d)
156 filings
152 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year, share counts where the company tagged them, and the buyback program's authorization. Amounts come exclusively from tagged SEC data, so years a company never tagged show no figure.
Program Authorized
$25,000,000
as of 2015-10-31
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2025-12-31 | $12,209,000 | 10-K, filed 2026-02-27 |
| 2024-12-31 | $10,959,000 | 10-K, filed 2026-02-27 |
| 2023-12-31 | $4,987,000 | 10-K, filed 2026-02-27 |
| 2022-12-31 | $1,959,000 | 10-K, filed 2025-02-28 |
| 2021-12-31 | $890,000 | 10-K, filed 2024-02-29 |
| 2020-12-31 | $1,523,000 | 10-K, filed 2023-03-09 |
| 2019-12-31 | $1,031,000 | 10-K, filed 2022-03-15 |
| 2018-12-31 | $0 | 10-K, filed 2019-02-27 |
| 2017-12-31 | $0 | 10-K, filed 2019-02-27 |
| 2016-12-31 | $2,500,000 | 10-K, filed 2019-02-27 |
| 2015-12-31 | $0 | 10-K, filed 2018-02-27 |
| 2014-12-31 | $0 | 10-K, filed 2017-03-02 |
| 2013-12-31 | $433,000 | 10-K, filed 2016-02-23 |
| 2012-12-31 | $0 | 10-K, filed 2014-02-28 |